基本信息
浏览量:0
职业迁徙
个人简介
Biography
After graduating from Hamilton College as a Chemistry major, Richard Edelson received his MD from the Yale School of Medicine (YSM). He then sequentially trained in Internal Medicine at the University of Chicago, Dermatology in the Harvard Program and Cancer Immunology at the National Institutes of Health. Before being recruited back to his alma mater as Chairman and Professor of the YSM Department of Dermatology in 1986, he was Director of the Immunobiology Group in Columbia University’s Comprehensive Cancer Center, Associate Director of that institution’s General Clinical Research Center and Professor and Director of Research in Columbia’s Dermatology Department.
While on the Yale faculty, he has served continuously as Chairman of the Department of Dermatology (1986-Present), and at overlapping times, has also been the Director of the Yale University Comprehensive Cancer Center (2003-9), YSM Deputy Dean overseeing all Clinical Departments (2000-3), Leader of the YSM Cancer Center’s Lymphoma Research Program and the YSM Faculty Representative to the Yale-New Haven Hospital Board of Trustees. He is an elected member of the American Society for Clinical Investigation and the Association of American Physicians, the Interurban Club, the Lotos Club and an honorary member of several international medical associations.
He is best known for two discoveries and their development. First, he introduced the unifying concept of Cutaneous T Cell Lymphoma (CTCL), as a malignancy of skin-homing malignant CD4 T cells. Second, he devised Extracorporeal Photochemotherapy, which became the first FDA-approved immunotherapy for any cancer. That therapy, through its induction, antigen loading and modulation of physiologic dendritic antigen presenting cells, is now regularly administered in the majority of university medical centers throughout the USA and Europe, to treat advanced CTCL, rejection of transplanted hearts and lungs, graft-versus-host disease following stem cell transplantation and autoimmune disorders. More than 70,000 patients have received a total of more than 3 million treatments.
He takes great pride in the level and breadth of the international acclaim of the present Yale Dermatology faculty members, all of whom were recruited to the Department on the Edelson watch. Each of the Department's four clinical sections (Medical, Pediatric and Surgical Dermatology, and Diagnostic Dermatopathology) is led by a recent president of the relevant national society. The clinical (residency and fellowship) training programs are distinguished by their production of academic and investigative dermatologists, having launched the careers of more than sixty full-time university-based faculty members, including eight current Dermatology Department chairmen (Stanford, Harvard, NYU, Albert Einstein, Howard, Oregon, Vermont and Eastern Virginia), the current Deputy Director of the National Cancer Institute and four current Directors of Dermatologic Surgery (Yale, Stanford, NYU and Vermont). The Yale Dermatology faculty currently ranks first nationally in its field, in terms of total federally funded dollars of competitive research support.
Dr. Edelson is the recipient of several National honors, including Castle and Connolly’s National Physician of the Year, the Dermatology Foundation’s Discovery Award, the American Skin Association’s National Mentorship Award and the Society of Investigative Dermatology’s Rothman Award for Career Contributions. He is one of eight selected graduates of the NIH Physician Scientist Training Program whose investigative careers were featured in an eight-hour audiobook, narrated by actor Alan Alda, released by Audible.Com in December 2020, as a tribute to pivotal federally funded scientifically-driven medical advances.
After graduating from Hamilton College as a Chemistry major, Richard Edelson received his MD from the Yale School of Medicine (YSM). He then sequentially trained in Internal Medicine at the University of Chicago, Dermatology in the Harvard Program and Cancer Immunology at the National Institutes of Health. Before being recruited back to his alma mater as Chairman and Professor of the YSM Department of Dermatology in 1986, he was Director of the Immunobiology Group in Columbia University’s Comprehensive Cancer Center, Associate Director of that institution’s General Clinical Research Center and Professor and Director of Research in Columbia’s Dermatology Department.
While on the Yale faculty, he has served continuously as Chairman of the Department of Dermatology (1986-Present), and at overlapping times, has also been the Director of the Yale University Comprehensive Cancer Center (2003-9), YSM Deputy Dean overseeing all Clinical Departments (2000-3), Leader of the YSM Cancer Center’s Lymphoma Research Program and the YSM Faculty Representative to the Yale-New Haven Hospital Board of Trustees. He is an elected member of the American Society for Clinical Investigation and the Association of American Physicians, the Interurban Club, the Lotos Club and an honorary member of several international medical associations.
He is best known for two discoveries and their development. First, he introduced the unifying concept of Cutaneous T Cell Lymphoma (CTCL), as a malignancy of skin-homing malignant CD4 T cells. Second, he devised Extracorporeal Photochemotherapy, which became the first FDA-approved immunotherapy for any cancer. That therapy, through its induction, antigen loading and modulation of physiologic dendritic antigen presenting cells, is now regularly administered in the majority of university medical centers throughout the USA and Europe, to treat advanced CTCL, rejection of transplanted hearts and lungs, graft-versus-host disease following stem cell transplantation and autoimmune disorders. More than 70,000 patients have received a total of more than 3 million treatments.
He takes great pride in the level and breadth of the international acclaim of the present Yale Dermatology faculty members, all of whom were recruited to the Department on the Edelson watch. Each of the Department's four clinical sections (Medical, Pediatric and Surgical Dermatology, and Diagnostic Dermatopathology) is led by a recent president of the relevant national society. The clinical (residency and fellowship) training programs are distinguished by their production of academic and investigative dermatologists, having launched the careers of more than sixty full-time university-based faculty members, including eight current Dermatology Department chairmen (Stanford, Harvard, NYU, Albert Einstein, Howard, Oregon, Vermont and Eastern Virginia), the current Deputy Director of the National Cancer Institute and four current Directors of Dermatologic Surgery (Yale, Stanford, NYU and Vermont). The Yale Dermatology faculty currently ranks first nationally in its field, in terms of total federally funded dollars of competitive research support.
Dr. Edelson is the recipient of several National honors, including Castle and Connolly’s National Physician of the Year, the Dermatology Foundation’s Discovery Award, the American Skin Association’s National Mentorship Award and the Society of Investigative Dermatology’s Rothman Award for Career Contributions. He is one of eight selected graduates of the NIH Physician Scientist Training Program whose investigative careers were featured in an eight-hour audiobook, narrated by actor Alan Alda, released by Audible.Com in December 2020, as a tribute to pivotal federally funded scientifically-driven medical advances.
研究兴趣
论文共 26 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Research Square (Research Square) (2022)
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 1.0 (2020): e000337-e000337
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn